SCHEMBL5528663

SCHEMBL5528663

CCCC(O)c1ccc(N(c2ccccc2)c2ccc(N(c3ccccc3)c3ccc(C(O)CCC)cc3)cc2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.48
RIPK1 Q13546 1/20 0.46
AOC3 Q16853 7/20 0.44
ALDH1A1 P00352 4/20 0.41
KDM4E B2RXH2 3/20 0.41
L3MBTL1 Q9Y468 2/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2D6 P10635 1/20 0.41
MAPT P10636 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
NR1H2 P55055 1/20 0.38
NR1H3 Q13133 1/20 0.38
SLC6A2 P23975 1/20 0.37
SLC6A4 P31645 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.36
GLA P06280 1/20 0.36
TSHR P16473 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11672044 0.89 LMNA (0.46) LMNARIPK1AOC3ALDH1A1KDM4E
SCHEMBL11673116 0.88 ASAH1 (0.46) LMNARIPK1ALDH1A1KDM4ESLC6A4
SCHEMBL348229 0.84 LMNA (0.67) LMNARIPK1AOC3ALDH1A1KDM4E
SCHEMBL28617318 0.84 LMNA (0.67) LMNARIPK1AOC3ALDH1A1KDM4E
SCHEMBL1295513 0.84 LMNA (0.67) LMNARIPK1AOC3ALDH1A1KDM4E
SCHEMBL540695 0.84 LMNA (0.67) LMNARIPK1AOC3ALDH1A1KDM4E
SCHEMBL21633858 0.82 LMNA (0.48) LMNARIPK1AOC3ALDH1A1KDM4E
SCHEMBL6055125 0.81 GAA (0.47) ALDH1A1L3MBTL1CYP3A4MAPTTDP1
SCHEMBL20078695 0.81 ALDH1A1 (0.43) AOC3ALDH1A1KDM4EL3MBTL1CYP1A2
SCHEMBL27532713 0.81 LMNA (0.52) LMNARIPK1AOC3L3MBTL1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070102695-A1 Crosslinkable substituted fluorene compounds and conjugated oligomers or polymers based thereon DOW GLOBAL TECHNOLOGIES INC. 2007-05-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070102695-A1 Crosslinkable substituted fluorene compounds and conjugated oligomers or polymers based thereon THEM6, PCNA, PARG LMNA 2585/4885RIPK1 3653/4885AOC3 459/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.